Advertisement
Screener

Alamar Biosciences, Inc. (ALMR) Retained Earnings

2.8 / 5 stars · 68/120 Roast Me

Alamar Biosciences, Inc. Retained Earnings

Alamar Biosciences, Inc. (ALMR) had Retained Earnings of -$203.30 million as of 2026-06-30, per its 10-Q filed 2026-08-11.

Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent

us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-11

  • 2026-06-30: Retained Earnings (Accumulated Deficit) -$203.30M.
  • 2026-03-31: Retained Earnings (Accumulated Deficit) -$190.10M.
  • 2025-12-31: Retained Earnings (Accumulated Deficit) -$168.78M.
Period endRetained Earnings (Accumulated Deficit)
2026-06-30-$203.30M
10-Q · filed 2026-08-11
2026-03-31-$190.10M
10-Q · filed 2026-05-08
2025-12-31-$168.78M
10-Q · filed 2026-08-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
908 Devices Inc. (MASS)United States$0.476B-9.53
EyePoint, Inc. (EYPT)United States$0.314B-3.96
Quanterix Corp (QTRX)United States$0.150B-1.65
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Seer, Inc. (SEER)United States$0.104B-1.34
Precipio, Inc. (PRPO)United States$0.043B-36.70
HARVARD BIOSCIENCE INC (HBIO)United States$0.037B-2.70
Bionano Genomics, Inc. (BNGO)United States$0.020B-0.42